Research Roundup

OFFICIAL PUBLICATION OF

by its subsidiary APPco

Debbie Rigby 06/06/2017

Debbie Rigby takes a look at the latest in research news Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study In this large multinational study, treatment with SGLT-2 inhibitor (canagliflozin, dapagliflozin, empagliflozin) versus other glucose lowering drugs was associated with a lower risk of

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

ACCC announces Chemist Warehouse/Sigma merger decision

Haha, right back at ya Anthony. "The Guild has always advocated for upholding the legislative intent of state and territory…

John Smith

ACCC announces Chemist Warehouse/Sigma merger decision

Paul, I'll try to make my point clearer, although it seems that everyone wants to argue against a point I'm…

John Smith

Retail workers suffering ‘serious mental and physical harm’

Is there a way we can access any signage to display?

Emma Anastasi

ACCC announces Chemist Warehouse/Sigma merger decision

John You have made some seriously flawed statements in the past, but the below will definitely form part of your…

Anthony Tassone

Research Roundup

Previous Forum: Ventolin scheduling

Next Guild launches immunisation course

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous Forum: Ventolin scheduling

Next Guild launches immunisation course

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.